Literature DB >> 2458201

The Abbott IMx automated benchtop immunochemistry analyzer system.

M Fiore1, J Mitchell, T Doan, R Nelson, G Winter, C Grandone, K Zeng, R Haraden, J Smith, K Harris.   

Abstract

We describe a new clinical laboratory instrument, the IMx, used to automate immunoassay testing in the clinical laboratory. The IMx incorporates a novel technology called Microparticle capture Enzyme ImmunoAssay (MEIA) for assays of high-molecular-mass analytes, and fluorescence polarization immunoassay (FPIA) for hapten assays. A front-surface fluorometer is used to quantify the enzymatic generation of fluorescent product at a rate proportional to the concentration of the analyte in an MEIA, and a fluorescence polarization optical system is used to quantify results in an FPIA. The microprocessor-based instrument uses a robotic arm with two degrees of freedom and a rotating carousel to process the samples for assay. One assay can be done on each of 24 patients' specimens in 30 to 40 min with "walk-away" automation. Calibration curves are stable for at least two weeks. Instrument control involves software-labeled "command keys," a numeric keypad, and an interactive display. Results are output to a thermal printer or computer interface.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458201

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  29 in total

1.  Comparison of a chemiluminescent immunoassay with two microparticle enzyme immunoassays for detection of hepatitis B virus surface antigen.

Authors:  R J Diepersloot; Y van Zantvliet-van Oostrom; C A Gleaves
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

2.  Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems.

Authors:  R J Diepersloot; H Dunnewold-Hoekstra; J Kruit-Den Hollander; F Vlaspolder
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

3.  Evaluation of three nucleic acid amplification methods for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.

Authors:  S X Wang; L Tay
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

4.  Evaluation of a commercial ligase chain reaction kit (Abbott LCx) for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary specimens.

Authors:  E Tortoli; F Lavinia; M T Simonetti
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

5.  Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2.

Authors:  K Abravaya; C Esping; R Hoenle; J Gorzowski; R Perry; P Kroeger; J Robinson; R Flanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

6.  Multi-wavelength immunoassays using surface plasmon-coupled emission.

Authors:  Evgenia Matveeva; Joanna Malicka; Ignacy Gryczynski; Zygmunt Gryczynski; Joseph R Lakowicz
Journal:  Biochem Biophys Res Commun       Date:  2004-01-16       Impact factor: 3.575

7.  Immunoassays based on directional surface plasmon-coupled emission.

Authors:  Evgenia Matveeva; Zygmunt Gryczynski; Ignacy Gryczynski; Joseph R Lakowicz
Journal:  J Immunol Methods       Date:  2004-03       Impact factor: 2.303

8.  Automated microparticle enzyme immunoassays for IgG and IgM antibodies to Toxoplasma gondii.

Authors:  J W Safford; G G Abbott; M C Craine; R G MacDonald
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

9.  Improvements in detection of antibody to hepatitis B core antigen by treating specimens with reducing agent in an automated microparticle enzyme immunoassay.

Authors:  A M Spronk; L Schmidt; C Krenc; L Pavlis-Jenkins; J Brady; S Taskar; L Angus-Finn; L Mimms
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

10.  Multicenter evaluation of five commercial rubella virus immunoglobulin G kits which report in international units per milliliter.

Authors:  W Dimech; A Bettoli; D Eckert; B Francis; J Hamblin; T Kerr; C Ryan; I Skurrie
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.